Patent details

Basic Information

Publication number:

EP1727803

PCT Application Number:

PCT/US/2004/023880

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047572664

PCT Publication Number:

WO/2005/103011

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N'-Ö3-(1H-PYRAZOL-5-YL)PHENYLÜ UREAS AND INTERMEDIATES THEREOF

French Title of Invention:

METHODES DE PREPARATION DE N-ARYL-N'-Ö3-(1H-PYRAZOL-5-YL) PHENYLUREESÜ SUBSTITUEES ET LEURS INTERMEDIAIRES

German Title of Invention:

VERFAHREN ZUR HERSTELLUNG VON SUBSTITUIERTE N-ARYL-N'-Ö3-(1H-PYRAZOL-5-YL)PHENYLÜ-HARNSTOFFE AND INTERMEDIATE DAVON.

SPC Number:

Dates

Filing date:

21/07/2004

Grant date:

07/03/2012

EP Publication Date:

07/03/2012

PCT Publication Date:

03/11/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/12/2006

EP B1 Publication Date:

07/03/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/07/2012

Expiration date:

21/07/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/07/2004

 

 

Name:

Arena Pharmaceuticals Inc.

Address:

6166 Nancy Ridge Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:

CARLETON Fiona M.

Address:

United States (US)

2

Name:

FRITCH John Robert

Address:

United States (US)

3

Name:

TEEGARDEN Bradley

Address:

United States (US)

4

Name:

LI Hongmei

Address:

United States (US)

5

Name:

LALLY Edward A.

Address:

United States (US)

Priority

Priority Number:

555626 P

Priority Date:

23/03/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 231/16;

Filing date	Document type	Number of pages